首页> 美国卫生研究院文献>Molecular Medicine >Oxidized Low-Density Lipoprotein–Dependent Platelet-Derived Microvesicles Trigger Procoagulant Effects and Amplify Oxidative Stress
【2h】

Oxidized Low-Density Lipoprotein–Dependent Platelet-Derived Microvesicles Trigger Procoagulant Effects and Amplify Oxidative Stress

机译:氧化的低密度脂蛋白依赖性血小板衍生微泡触发促凝作用并放大氧化应激

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The fundamental mechanisms that underlie platelet activation in atherothrombosis are still obscure. Oxidative stress is involved in central features of atherosclerosis. Platelet-derived microvesicles (PMVs) could be important mediators between oxidative stress and platelet activation. CD36 could be a receptor of PMVs, thus generating a PMV–CD36 complex. We aimed to investigate the detailed pathway by which oxidative damage contributes to platelet activation by the PMV–CD36 complex. We found that oxidized low-density lipoprotein stimulated the generation of PMVs. PMVs enhanced normal platelet activation, as assessed by the expression of integrin αIIbβ3, secretion of soluble P-selectin and platelet aggregation, but CD36-deficient platelets were not activated by PMVs. The function of the PMV–CD36 complex was mediated by the MKK4/JNK2 signaling axis. Meanwhile, PMVs increased the level of 8-iso-prostaglandin-F2α, a marker of oxidative stress, in a CD36- and phosphatidylserine-dependent manner. We concluded that PMVs are important mediators between oxidative stress and platelet activation. PMVs and CD36 may be effective targets for preventing platelet activation in cardiovascular diseases.
机译:动脉粥样硬化中血小板活化的基础机制仍然不清楚。动脉粥样硬化的主要特征涉及氧化应激。血小板衍生的微囊泡(PMV)可能是氧化应激和血小板活化之间的重要介体。 CD36可能是PMV的受体,从而产生PMV-CD36复合物。我们旨在研究氧化损伤通过PMV–CD36复合物促进血小板活化的详细途径。我们发现氧化的低密度脂蛋白刺激了PMV的产生。通过整联蛋白αIIbβ3的表达,可溶性P-选择蛋白的分泌和血小板聚集评估,PMV增强了正常的血小板活化,但PMV并未激活CD36缺陷型血小板。 PMV–CD36复合物的功能由MKK4 / JNK2信号转导轴介导。同时,PMV以CD36和磷脂酰丝氨酸依赖性方式增加了8-异前列腺素F2α(氧化应激的标志物)的水平。我们得出的结论是,PMV是氧化应激和血小板活化之间的重要介体。 PMV和CD36可能是预防心血管疾病中血小板活化的有效靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号